The purpose of the abatacept pregnancy registry is to monitor planned and unplanned
pregnancies exposed to abatacept, to evaluate the possible teratogenic effects (that is, any
abnormal development) of this medication in the pregnancy outcome and to follow live born
infants for one year after birth.
Details
Lead Sponsor:
Bristol-Myers Squibb
Collaborators:
The Organization of Teratology Information Specialists University of California, San Diego